Did any adverse reactions happen during this study?
There were participants who had adverse reactions in this study.
How many participants had serious adverse reactions?
- 2.3% of participants who took dapagliflozin had serious adverse reactions. This was 50 out of 2,149 participants.
- 2.1% of participants who took the placebo had serious adverse reactions. This was 45 out of 2,149 participants.
How many participants stopped taking study treatment due to adverse reactions?
- 1.5% of participants stopped taking dapagliflozin due to adverse reactions. This was 33 out of 2,149 participants.
- 1.4% of participants stopped taking placebo due to adverse reactions. This was 30 out of 2,149 participants.